novo nordisk semaglutide pill FDA approves oral Rybelsus to treat type 2 diabetes Novo's Oral Wegovy: Dead-Cat Bounce

Side Effects The most common tirzepatide side effects include abdominal pain, burping, constipation, diarrhea, dyspepsia, fatigue, gastroesophageal reflux disease, hair loss, hypersensitivity reactions, injection site reactions, nausea, and vomiting, which affects 5% or more patients

In December 2025, the administration also introduced the BALANCE (Better Approaches to Lifestyle and Nutrition for Comprehensive hEalth) model, a five year CMS Innovation Center (CMMI) model that intends to expand access to obesity drugs in Medicaid and Medicare by negotiating lower GLP-1 prices with manufacturers

Not available to Molina Medicaid or Medicare beneficiaries

Moreover, dont hesitate to reach out to your healthcare provider for personalized advice and adjustments to your treatment plan